Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Effects of resveratrol pretreatment on endoplasmic reticulum stress and cognitive function after surgery in aged mice

BMC Anesthesiology201818:141

https://doi.org/10.1186/s12871-018-0606-5

  • Received: 2 May 2018
  • Accepted: 1 October 2018
  • Published:
Open Peer Review reports

Abstract

Background

Postoperative cognitive dysfunction (POCD) seriously reduces quality of life and is associated with increased morbidity and mortality. The causes and neuropathogenesis of POCD remain largely unknown. Resveratrol, a sirtuin 1 (Sirt1) activator, is a polyphenol compound found in red wine that has protective functions in neuropathology paradigms. Endoplasmic reticulum stress (ERS) is a primary cellular response that activates the unfolded protein response (UPR). ERS and UPR mediate molecular and biochemical mechanisms related to neurodegeneration; however, the roles of ERS and Sirt1 in POCD remain unclear. The properties of resveratrol might be useful in the setting of POCD.

Methods

In the present study, we investigated learning and memory function and ERS pathways in aged mice after surgery under local anesthesia, and we evaluated the effects of resveratrol pretreatment.

Results

We found that resveratrol attenuated postoperative learning and memory impairment in aged mice postoperatively but did not alter locomotor activity. Resveratrol significantly decreased postoperative expression of ERS pathway UPR-related proteins and inflammatory mediators including nuclear factor-κB (NF-κB) in the hippocampus. This was accompanied by higher Sirt1 protein expression levels. Pretreatment with resveratrol did not affect the number of hippocampal neurons in aged mice after surgery.

Conclusion

Overall, resveratrol pretreatment attenuated short-term learning and memory impairment and the ERS pathway UPR in aged mice after surgery under local anesthesia.

Keywords

  • Resveratrol
  • Endoplasmic reticulum stress
  • Cognitive function
  • Surgery
  • Aged mice

Background

Aged patients are prone to postoperative decreases in learning and memory function, resulting in decreased quality of life and increased social burden [13]. Improvements of anesthesia and surgical techniques have led to larger numbers of older patients receiving anesthesia and surgery. These patients are more likely to exhibit postoperative learning and memory impairment.

Annually, there are approximately 2.5 million surgical operations worldwide [4]. Improving postoperative cognitive function and preventing postoperative cognitive dysfunction (POCD) are therefor of great significance. The factors of POCD are extremely complex [5, 6], but recent studies have focused on the impacts of anesthesia factors and general anesthesia drugs, especially inhalation agents such as isoflurane and sevoflurane, on the central nervous system [710]. Patients undergoing general or even regional or local anesthesia for surgical treatment can experience POCD [11, 12]. One group found that rats under intravenous anesthesia during right carotid artery exploration still exhibited POCD compared with inhalation anesthesia [13]. It is important to study the effect of surgery on the central nervous system and neuronal inflammation to clarify the mechanism(s) of POCD and identify appropriate interventions.

Endoplasmic reticulum stress (ERS) is the initial response of cells under stress [14, 15]. ERS has been linked with cognitive function in inhaled anesthetics-induced cognitive dysfunction and neurodegenerative conditions such as Alzheimer’s disease [16, 17]. It is suggested that ERS played an important role in surgery-induced cognitive impairment in animal models and ERS could be attenuated by some intervening [18, 19].. The unfolded protein response (UPR) in the ERS pathway involves three membrane proteins that are important endoplasmic reticulum receptors: PERK (the PKR-like ER protein kinase), IRE1 (the inositol-equiring enzyme 1), and ATF6 (the activating transcription factor 6). The released BiP/GRP78 activates important downstream pathways including PERK/EIF2α, IRE1 /XBP1, and ATF6 [20]. IRE1 in the UPR is a highly conservative transmembrane protein that localizes to the endoplasmic reticulum and can activate including nuclear factor-κB (NF-κB) [21]. C/EBP homologous protein (CHOP) is thought to be a pro-apoptotic transcription factor and plays a critical role in ERS-induced apoptosis [22].

Resveratrol is found naturally in grapes, mulberry, and other plants. It is a natural polyphenol and can activate sirtuin 1 (Sirt1). It has antioxidant effects and affects downstream signaling pathways [23]. Numerous in vivo and in vitro studies have demonstrated that resveratrol can protect the myocardium and exert anti-tumor, anti-oxidative, anti-inflammatory, and neuroprotective effects by activating Sirt1 [2427].

However, the effect of resveratrol on the ERS in POCD is not clear. The goal of this study was to investigate whether resveratrol pretreatment affects learning and memory function in aged mice after surgery. We examined the effects on the ERS-related inflammatory marker NF-κB and ERS-related UPR-specific proteins such as PERK, GRP78, CHOP, XBP1u, and IRE1α.

Methods

Animals

The experiments utilized 18-month-old male C57BL/6 mice that were housed at the Animal Experimental Center of Zhongshan Hospital, Fudan University. The mice were housed in cages at a temperature of 22 °C for 12 h. All the experimental protocols were approved by the animal ethics committee of Zhongshan Hospital Affiliated to Fudan University, China. Reference number for the ethics approval is 2016–0130. Mice were randomly divided into three groups: resveratrol (n = 10), surgery (n = 10), and control (n = 10). Mice in the resveratrol group were pretreated with resveratrol for 7 days at a dose of 100 mg/kg via intraperitoneal injection. The mice in the surgery group were given 7 days of the same amount of vehicle intraperitoneally. Mice in the resveratrol and surgery groups underwent exploratory laparotomy under local anesthesia on the 7th day after intraperitoneal injection. Mice in the control group received 7 days of intraperitoneal vehicle without surgery.

Surgical model

The mice model in our study was modified from the model in series studies explored by Xie C [28, 29]. Mice were gently fixed with a paper tape on a plastic separator, and covered with a 37 °C constant temperature electric blanket. All surgical instruments were sterilized by autoclaving. Bupivacaine (0.5%, 0.1 ml) was applied to the skin and subcutaneous tissue in the abdominal region of each mouse. A 1.5 cm incision was made parallel to the median line on the right side of the midline, followed by gentle abdominal exploration. Then the muscle fascia and skin were sutured with 3–0 sterile silk. Surgery lasted 5 min, without sedative drugs or antibiotics. Each mouse was operated on with sterile instruments and newly opened sterile sutures. All mice breathed spontaneously throughout surgery, and we monitored their respiration rate, limb color, and temperature. Postoperatively, the mice were returned to the original environment to continue feeding with regular observation of wounds and vital signs. Saline was used once per day for 2 or 7 days post-surgery to avoid the infections.

Open field test

Locomotor activity was tested in the open field at 1 day postoperatively. The mice were moved from the home cage to the corner of the open field (120*120 cm), which was divided into a grid of 3*3 squares. Animal movement in the area was recorded for 10 min. The total distance traveled and mean speed were recorded and quantified with Any-Maze software.

Fear conditioning system (FCS)

The animals received FCS pairing training 24 h postoperatively. At 48 h and 7 days after surgery, the animals were subjected to context and tone testing.

Behavioral testing using FCS was divided into two stages of training and testing. The training phase was performed by placing the mouse in a test chamber (30 cm * 30 cm * 45 cm) for 180 s, giving a 2-Hz 60-s sound stimulation, then a foot shock immediately after the end of the stimulus (0.8 mA for 0.5 s). This training process has two consecutive periods, with a 2-min middle interval for a rest.

The first context test was performed 30 min after the end of the training, and each mouse could remain in the same chamber for 390 s. Learning and memory evaluation for the context test was a percentage of the lag time, and freeze was defined as the percentage of time spent not moving in the second 180-s period. The first tone test was performed 90 min after the end of the training. Each mouse could stay in the same chamber for 390 s. The same tone was played in the second 180 s, but without a foot shock. The learning and memory evaluation in the tone test was the freezing time percentage. The same procedures for the context and tone tests were performed 48 h and 7 days after surgical intervention.

At the end of the experiment, the mice were returned to their home cage for feeding. After testing each mouse, the site was wiped with 75% alcohol to eliminate smell interference.

Nissl staining

After the FCS at 7 days postoperatively, the mice (n = 4 in each group) were deeply anesthetized and perfused with normal saline, followed by 4% paraformaldehyde. Brains were fixed, dehydrated in a sucrose gradient, and series sectioned. The section thickness was 20 μm. Images were taken at 400 times magnification, for 75 fields per group. The numbers of hippocampal neurons were calculated.

Western blot

After the FCS at 7 days postoperatively, the mice (n = 6 in each group) were sacrificed under deep anesthesia. The hippocampal tissues were removed out and then immediately placed in liquid nitrogen and subsequently stored at − 80°Cuntil tissue homogenization. The expression of Sirt1 and ERS unfolding protein-related proteins were detected by western blot. Samples were centrifuged, and protein concentrations were determined with the bicinchoninic acid method. Equal amounts were then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to membranes, and incubated with appropriate antibodies. Western blotting assay was performed six times. β-actin was used as the internal reference (Santa Cruz); other antibodies were Sirt1 (Santa Cruz), IRE1α (Cell Signaling Technology), PERK (Cell Signaling Technology), XBP1u (Santa Cruz), CHOP (Cell Signaling Technology), GRP78 (Santa Cruz), and NF-κB (Cell Signaling Technology). Each experiment was repeated at least four times. Integrated density values of specific proteins were quantified using ImageJ software. Relative expression levels of proteins were normalized to β-actin.

Real-time PCR

Total RNA was isolated from homogenized hippocampal tissues using the Trizol extraction method. Real-time quantitative PCR was used to detect mRNA expression. β-actin was used as an internal control. The primers were Sirt1 sense strand CAGCATCTTGCCTGATTTGTAA, antisense strand TGGGGTATAGAACTTGGAATTAGTG; IRE1α sense strand AGAATCAGACGAGCACCCAAATG, antisense strand GAGAATGTTGTGGGGCTTCAGGT. The relative expression of mRNA was quantified using the 2–ΔΔCt method. The results were normalized to β-actin as reference gene.

Statistical analysis

SPSS19 software was used to analyze the data for normality and variance homogeneity. Data are expressed as mean ± standard deviation. The results were compared using two-way analysis of variance in Fig. 2. The results were compared using one-way analysis of variance in Figs. 1, 3 and 4. Two-tailed tests were employed in all comparisons. Differences were considered significant at p < 0.05. Graphs were created using GraphPad Prism 6.
Fig. 1
Fig. 1

The distance (a) and mean speed (b) in the open field test 1 day postoperatively; Con, control; Res, resveratrol; Sur, surgery. The number of mice in each group was 10

Results

Neither surgery nor resveratrol pretreatment affected locomotor activity

Surgery did not significantly affect the distance or mean speed in the open field test. Similarly, resveratrol did not significantly affect the distance or mean speed compared with the surgery group (Fig. 1a and b).

Pretreatment with resveratrol attenuated the POCD in aged mice

Compared with the control group, the freezing times for both the context and tone tests at 24 h, 48 h, and 7 days postoperatively were significantly decreased in the surgery group. The freezing times of the resveratrol group were significantly higher than that of surgery group (Fig. 2a and b). These results indicated that pretreatment with resveratrol attenuated learning and memory impairment in aged mice.
Fig. 2
Fig. 2

The freezing time percentages for the context (a) and tone (b) tests at 24 h, 48 h, and 7 days postoperatively; Con, control; Res, resveratrol; Sur, surgery. *P < 0.05. The number of mice in each group was 10

Pretreatment with resveratrol increased hippocampal Sirt1 and Sirt1-mRNA expression

The protein and mRNA levels of Sirt1 in the surgery and resveratrol groups were significantly different compared with those in the control group (Figs. 3a, 4a and d). Western blot analysis revealed that Sirt1 levels were significantly higher in the resveratrol pretreatment group compared to the surgery group (Fig. 4a and d). Real-time PCR showed greater Sirt1-mRNA expression in the resveratrol pretreatment group compared to the surgery group (Fig. 3a). This indicated that resveratrol preferentially stimulated Sirt1 expression in the hippocampus.
Fig. 3
Fig. 3

Sirt1-mRNA (a) and IRE1α-mRNA (b) expression in the hippocampus and CA1 neuron density (c) at 7 days postoperatively; All values were expressed as fold changes over the mean values of control and were presented as mean ± SD (n = 4). *P < 0.05. Con, control; Res, resveratrol; Sur, surgery

Fig. 4
Fig. 4

Sirt1 and unfolded protein response-related proteins IRE1α, PERK, XBP1, CHOP, GRP78, and NF-κB in the hippocampus (a, b) Western blot results and (c, d) relative protein expression levels at 7 days postoperatively. All values were expressed as fold changes over the mean values of control and were presented as mean ± SD (n = 4). *P < 0.05. Con, control; Res, resveratrol; Sirt1, sirtuin 1; Sur, surgery

Resveratrol attenuated learning and memory impairment in aged mice

After the final behavioral test at 7 days postoperatively, hippocampal sections were subjected to Nissl staining. There was no significant difference in hippocampal neuron density between the resveratrol and surgery groups (Fig. 3c). This indicated that resveratrol had no effect on the number of neurons in the hippocampus.

Pretreatment with resveratrol attenuated ERS-induced UPR in the hippocampus of aged mice

Western blot analysis showed that the expression levels of UPR-related proteins in the surgery group were significantly increased than the control group. The expression levels of UPR-related proteins in the resveratrol group were significantly different from the other two groups. Compared with the surgery group, the expressions of CHOP, IRE1α, XBP1u, PERK, and NF-κB were significantly decreased in the resveratrol group (Fig. 4). Real-time PCR results showed significantly lower hippocampal IRE1α mRNA levels in the resveratrol pretreatment group compared to the surgery group (Fig. 3b). These indicated that pretreatment with resveratrol could attenuate surgery induced UPR and reduce the expression of inflammatory mediators.

Discussion

Mice receiving exploratory laparotomy under local anesthesia exhibited learning and memory impairment. This demonstrates that surgery induced cognitive dysfunction in aged mice without general anesthesia or inhalation anesthetics [28]. The expression levels of Sirt1 and UPR-related proteins in the hippocampus were significantly different between the surgery and control groups. Sirt1 expression was increased in the surgery group and could play an important role in the regulation of cellular functions under stress, but it was not associated with a neuroprotective effect yet. The result of present study was consistent with some studies. [30].

The results confirmed that resveratrol pretreatment of aged mice prior to local anesthesia could activate hippocampal expression of Sirt1. The effects of resveratrol have been studied and reported in several diseases models, but the numerous pathways it influences remain to be fully elucidated. Resveratrol can directly activate Sirt1 expression at transcriptional and translational levels, and it exerts its deacetylation pathway downstream [3133]. However, recent studies have shown that many mediators are involved in resveratrol-induced Sirt1 expression, suggesting that resveratrol both directly and indirectly activates Sirt1 [34, 35].

Resveratrol exert anti-tumor, anti-oxidative, anti-inflammatory, and neuroprotective effects by activating Sirt1. Resveratrol has been suggested to enhance/increase ER stress in cancer cells [3638]. The specific mechanism of resveratrol anti-tumor and neuroprotective effects remain unknown. Several studies have proved that resveratrol could suppress ER stress in heart and brain [39, 40]. We found that resveratrol pretreatment attenuated postoperative learning and memory impairment in aged mice. The mechanism of resveratrol in cognitive function is very complex, probably independent of the role of Sirt1 [4143]. The present findings show the possibility that ERS suppression could be one of the mechanisms.

The results indicated that resveratrol pretreatment could attenuate the ERS pathway UPR in the hippocampus of aged mice under local anesthesia. Resveratrol ameliorates ERS by many mechanisms, such as downregulating CHOP and GRP78 gene expression and attenuating caspase-3 activity and ERS could be mediated by some mechanisms as well [44]. Resveratrol was shown to prevent doxorubicin-induced cardiotoxicity in H9c2 cells by inhibiting ERS and Sirt1 pathway activation [39]. ERS could be involved in cognitive function. Amelioration of ERS may therefore serve as a novel strategy to alleviate cognitive function triggered by microcystin-leucine-arginine [45]. Honokiol abrogates chronic restraint stress-induced cognitive impairment and depressive-like behavior by blocking ERS in the mouse hippocampus [46].

Although our results show that resveratrol can alleviate ERS in a POCD model, the specific pathway remains unclear. The target for ER-specificity is unknown, and the mechanisms of ER-related pathways need to be elucidated [47, 48]. Amelioration of ERS could be explored in further studies. Resveratrol pharmacokinetics still need to be investigated to identify the appropriate dose. The anti-inflammatory and anti-apoptotic effects of resveratrol on ERS and other mechanisms of action are interrelated and need to be clarified. Specifically, it will be important to determine whether resveratrol can affect cognitive function in animals treated with antagonists of ERS. The relationship among resveratrol, Sirt1, ERS and cognitive function remain further study. We would focus on the association between ER stress and Sirt1 in vitro and in vivo in our following study.

Conclusion

In summary, resveratrol pretreatment could activate Sirt1 expression and reduce postoperative ERS in aged mice. Resveratrol also attenuates POCD. These results reveal an important role of ERS in surgery under local anesthesia and provide a potential study target for POCD.

Abbreviations

ATF6: 

The activating transcription factor 6

CHOP: 

C/EBP homologous protein

ERS: 

Endoplasmic reticulum stress

FCS: 

Fear conditioning system

IRE1: 

The inositol-equiring enzyme 1

NF-κB: 

Nuclear factor-κB

PERK: 

Rhe PKR-like ER protein kinase

POCD: 

Postoperative cognitive dysfunction

Sirt1: 

Sirtuin 1

UPR: 

Unfolded protein response

Declarations

Funding

This study was supported by the Department of Anesthesiology, Zhongshan Hospital Affiliated to Fudan University.

Availability of data and materials

All data generated and analysed during this study are included in this published article.

Authors’ contributions

BW performed animal experiments, Nissl staining, realtime PCR and western blotting, and was responsible for the study design, data collection, data analysis, manuscript preparation, and manuscript writing. WX and ZX was responsible for revising it critically for important intellectual content. SG was responsible for providing experimental ideas and review manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

All experiments were performed in accordance with the Chinese Guidance for the Care and Use of Laboratory Animals. The whole study was reviewed and approved by the Ethics Committee of Zhongshan Hospital Fudan University, and the Ethical code is Z2016–0130.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Anesthesia, Zhongshan Hospital, Fudan University, Shanghai, 200032, China

References

  1. Strom C, Rasmussen LS. Challenges in anaesthesia for elderly. Singap Dent J. 2014;35C:23–9.View ArticleGoogle Scholar
  2. Hartholt KA, van der Cammen TJ, Klimek M. Postoperative cognitive dysfunction in geriatric patients. Z Gerontol Geriatr. 2012;45(5):411–6.View ArticleGoogle Scholar
  3. Terrando N, Eriksson LI, Eckenhoff RG. Perioperative neurotoxicity in the elderly: summary of the 4th international workshop. Anesth Analg. 2015;120(3):649–52.View ArticleGoogle Scholar
  4. Berger M, Nadler JW, Browndyke J, Terrando N, Ponnusamy V, Cohen HJ, Whitson HE, Mathew JP. Postoperative cognitive dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the Elderly. Anesthesiol Clin. 2015;33(3):517–50.View ArticleGoogle Scholar
  5. Androsova G, Krause R, Winterer G, Schneider R. Biomarkers of postoperative delirium and cognitive dysfunction. Front Aging Neurosci. 2015;7:112.View ArticleGoogle Scholar
  6. Setacci C, Sirignano A, Ricci G, Spagnolo AG, Pugliese F, Speziale F. A new ethical and medico-legal issue: vascular surgery and the postoperative cognitive dysfunction. J Cardiovasc Surg. 2015;56(4):607–15.Google Scholar
  7. Tao G, Zhang J, Zhang L, Dong Y, Yu B, Crosby G, Culley DJ, Zhang Y, Xie Z. Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3β activation in young mice. Anesthesiology. 2014;121(3):510–27.View ArticleGoogle Scholar
  8. Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu Q, Hua F, Xu G, Yu P. Sevoflurane Postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. SCI REP-UK. 2014;4:7317.View ArticleGoogle Scholar
  9. Tachibana S, Hayase T, Osuda M, Kazuma S, Yamakage M. Recovery of postoperative cognitive function in elderly patients after a long duration of desflurane anesthesia: a pilot study. J Anesth. 2015;29(4):627–30.View ArticleGoogle Scholar
  10. Sellbrant I, Brattwall M, Jildenstal P, Warren-Stomberg M, Forsberg S, Jakobsson JG. Anaesthetics and analgesics; neurocognitive effects, organ protection and cancer reoccurrence an update. Int J Surg. 2016;34:41–6.View ArticleGoogle Scholar
  11. Davis N, Lee M, Lin AY, Lynch L, Monteleone M, Falzon L, Ispahany N, Lei S. Postoperative cognitive function following general versus regional anesthesia: a systematic review. J Neurosurg Anesthesiol. 2014;26(4):369–76.View ArticleGoogle Scholar
  12. Xie Z, McAuliffe S, Swain CA, Ward SAP, Crosby CA, Zheng H, Sherman J, Dong Y, Zhang Y, Sunder N, et al. Cerebrospinal fluid Aβ to tau ratio and postoperative cognitive change. Ann Surg. 2013;258(2):364–9.View ArticleGoogle Scholar
  13. Zhang J, Tan H, Jiang W, Zuo Z. The choice of general anesthetics may not affect Neuroinflammation and impairment of learning and memory after surgery in elderly rats. J Neuroimmune Pharm. 2015;10(1):179–89.View ArticleGoogle Scholar
  14. Zhao Y, Han Y, Bu DF, Zhang J, Li QR, Jin HF, Du JB, Qin J. Reduced AKT phosphorylation contributes to endoplasmic reticulum stress-mediated hippocampal neuronal apoptosis in rat recurrent febrile seizure. Life Sci. 2016;153:153–62.View ArticleGoogle Scholar
  15. Zhang Y, Liu W, Zhou Y, Ma C, Li S, Cong B. Endoplasmic reticulum stress is involved in restraint stress-induced hippocampal apoptosis and cognitive impairments in rats. Physiol Behav. 2014;131:41–8.View ArticleGoogle Scholar
  16. Xiang C, Wang Y, Zhang H, Han F. The role of endoplasmic reticulum stress in neurodegenerative disease. Apoptosis. 2017;22(1):1–26.View ArticleGoogle Scholar
  17. Ge HW, Hu WW, Ma LL, Kong FJ. Endoplasmic reticulum stress pathway mediates isoflurane-induced neuroapoptosis and cognitive impairments in aged rats. Physiol Behav. 2015;151:16–23.View ArticleGoogle Scholar
  18. Tian A, Ma H, Zhang R, Cui Y, Wan C. Edaravone improves spatial memory and modulates endoplasmic reticulum stress-mediated apoptosis after abdominal surgery in mice. Exp Ther Med. 2017;14(1):355–60.View ArticleGoogle Scholar
  19. Li X, Wang S, Dai J, Yan L, Zhao S, Wang J, Sun Y. Homoharringtonine prevents surgery-induced epidural fibrosis through endoplasmic reticulum stress signaling pathway. Eur J Pharmacol. 2017;815:437–45.View ArticleGoogle Scholar
  20. Schroder M. Endoplasmic reticulum stress responses. Cell Mol Life Sci. 2008;65(6):862–94.View ArticleGoogle Scholar
  21. Kaneko M, Niinuma Y, Nomura Y. Activation signal of nuclear factor-kappa B in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2. Biol Pharm Bull. 2003;26(7):931–5.View ArticleGoogle Scholar
  22. Biwer LA, Isakson BE. Endoplasmic reticulum-mediated signalling in cellular microdomains. Acta Physiol (Oxf). 2017;219(1):162–75.View ArticleGoogle Scholar
  23. Bavaresco L, Lucini L, Busconi M, Flamini R, De Rosso M. Wine resveratrol: from the ground up. Nutrients. 2016;8(4).View ArticleGoogle Scholar
  24. Oomen CA, Farkas E, Roman V, van der Beek EM, Luiten PG, Meerlo P. Resveratrol preserves cerebrovascular density and cognitive function in aging mice. Front Aging Neurosci. 2009;1:4.View ArticleGoogle Scholar
  25. Song L, Chen L, Zhang X, Li J, Le W. Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Biomed Res Int. 2014;2014:483501.PubMedPubMed CentralGoogle Scholar
  26. Lancon A, Frazzi R, Latruffe N. Anti-oxidant, anti-inflammatory and anti-Angiogenic properties of resveratrol in ocular diseases. Molecules. 2016;21(3).View ArticleGoogle Scholar
  27. Yang T, Wang L, Zhu M, Zhang L, Yan L. Properties and molecular mechanisms of resveratrol: a review. Pharmazie. 2015;70(8):501–6.PubMedGoogle Scholar
  28. Xu Z, Dong Y, Wang H, Culley DJ, Marcantonio ER, Crosby G, Tanzi RE, Zhang Y, Xie Z. Peripheral surgical wounding and age-dependent Neuroinflammation in mice. PLoS One. 2014;9(5):e96752.View ArticleGoogle Scholar
  29. Dong Y, Xu Z, Huang L, Zhang Y, Xie Z. Peripheral surgical wounding may induce cognitive impairment through interlukin-6-dependent mechanisms in aged mice. Med Gas Res. 2016;6(4):180–6.View ArticleGoogle Scholar
  30. Meng Z, Li J, Zhao H, Liu H, Zhang G, Wang L, Hu HE, Li DI, Liu M, Bi F, et al. Resveratrol relieves ischemia-induced oxidative stress in the hippocampus by activating SIRT1. Exp ther med. 2015;10(2):525–30.PubMedPubMed CentralGoogle Scholar
  31. Li X, Zhou M, Wang X, Ji M, Zhou Z, Yang J. Resveratrol pretreatment attenuates the isoflurane-induced cognitive impairment through its anti-inflammation and -apoptosis actions in aged mice. J Mol Neurosci. 2014;52(2):286–93.View ArticleGoogle Scholar
  32. Diaz-Gerevini GT, Repossi G, Dain A, Tarres MC, Das UN, Eynard AR. Beneficial action of resveratrol: how and why? NUTRITION. 2016;32(2):174–8.View ArticleGoogle Scholar
  33. Yang T, Li S, Zhang X, Pang X, Lin Q, Cao J. Resveratrol, sirtuins, and viruses. Rev Med Virol. 2015;25(6):431–45.View ArticleGoogle Scholar
  34. Zhang F, Liu J, Shi JS. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol. 2010;636(1–3):1–7.View ArticleGoogle Scholar
  35. Fu Y, Wang Y, Du L, Xu C, Cao J, Fan T, Liu J, Su X, Fan S, Liu Q, et al. Resveratrol inhibits ionising irradiation-induced inflammation in MSCs by activating SIRT1 and limiting NLRP-3 inflammasome activation. Int J Mol Sci. 2013;14(7):14105–18.View ArticleGoogle Scholar
  36. Li YW, Yang FC, Lu HQ, Zhang JS. Hepatocellular carcinoma and hepatitis B surface protein. World J Gastroenterol. 2016;22(6):1943–52.View ArticleGoogle Scholar
  37. Park JW, Woo KJ, Lee JT, Lim JH, Lee TJ, Kim SH, Choi YH, Kwon TK. Resveratrol induces pro-apoptotic endoplasmic reticulum stress in human colon cancer cells. Oncol Rep. 2007;18(5):1269–73.PubMedGoogle Scholar
  38. Wang FM, Galson DL, Roodman GD, Ouyang H. Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cells. Exp Hematol. 2011;39(10):999–1006.View ArticleGoogle Scholar
  39. Lou Y, Wang Z, Xu Y, Zhou P, Cao J, Li Y, Chen Y, Sun J, Fu L. Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway. Int J Mol Med. 2015;36(3):873–80.View ArticleGoogle Scholar
  40. Lin Y, Zhu J, Zhang X, Wang J, Xiao W, Li B, Jin L, Lian J, Zhou L, Liu J. Inhibition of cardiomyocytes hypertrophy by resveratrol is associated with amelioration of endoplasmic reticulum stress. Cell Physiol Biochem. 2016;39(2):780–9.View ArticleGoogle Scholar
  41. Feng Y, Cui Y, Gao JL, Li MH, Li R, Jiang XH, Tian YX, Wang KJ, Cui CM, Cui JZ. Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-kappaB signaling pathway in experimental traumatic brain injury. Int J Mol Med. 2016;37(4):921–30.View ArticleGoogle Scholar
  42. Evans HM, Howe PR, Wong RH. Effects of resveratrol on cognitive performance, mood and cerebrovascular function in post-menopausal women; a 14-week randomised placebo-controlled intervention trial. Nutrients. 2017;9(1):27.View ArticleGoogle Scholar
  43. Tian Z, Wang J, Xu M, Wang Y, Zhang M, Zhou Y. Resveratrol improves cognitive impairment by regulating apoptosis and synaptic plasticity in Streptozotocin-induced diabetic rats. Cell Physiol Biochem. 2016;40(6):1670–7.View ArticleGoogle Scholar
  44. Gaballah HH, Zakaria SS, Elbatsh MM, Tahoon NM. Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson's disease. Chem Biol Interact. 2016;251:10–6.View ArticleGoogle Scholar
  45. Cai F, Liu J, Li C, Wang J. Critical role of endoplasmic reticulum stress in cognitive impairment induced by microcystin-LR. Int J Mol Sci. 2015;16(12):28077–86.View ArticleGoogle Scholar
  46. Jangra A, Dwivedi S, Sriram CS, Gurjar SS, Kwatra M, Sulakhiya K, Baruah CC, Lahkar M. Honokiol abrogates chronic restraint stress-induced cognitive impairment and depressive-like behaviour by blocking endoplasmic reticulum stress in the hippocampus of mice. Eur J Pharmacol. 2016;770:25–32.View ArticleGoogle Scholar
  47. Guo R, Liu W, Liu B, Zhang B, Li W, Xu Y. SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: an insight into endoplasmic reticulum stress response mechanism. Int J Cardiol. 2015;191:36–45.View ArticleGoogle Scholar
  48. Liu LQ, Fan ZQ, Tang YF, Ke ZJ. The resveratrol attenuates ethanol-induced hepatocyte apoptosis via inhibiting ER-related Caspase-12 activation and PDE activity in vitro. Alcohol Clin Exp Res. 2014;38(3):683–93.View ArticleGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement